Gilead Sciences / Avalere Health / Human Services / /
Country
United States / /
Currency
USD / /
Event
FDA Phase / /
IndustryTerm
restricted pharmacy networks / treatment of HCV / co-insurance tiers / social/ancillary services / drug manufacturers / HCV treatment / health insurance / direct-to-consumer advertising practices / insurance / health insurance marketplaces / manufacturing / long-term solutions / discriminatory health insurance industry practices / health insurance industries / supportive/ancillary care services / healthcare / imaging / federal health insurance marketplaces / /
MarketIndex
Consumer Price / /
MedicalCondition
DF / HIV / disease / chronic health conditions / HCV / diseases / AIDS / HIV/AIDS / infection / Viral Hepatitis / chronic hepatitis C / chronic conditions / /
MedicalTreatment
antiretroviral therapy / /
Organization
Commonwealth Fund / U.S. Department of Health and Human Services / U.S. Food and Drug Administration / Fair Pricing Coalition / HHS Center for Consumer Information and Insurance Oversight / Medicare / /
Person
Martin Delaney / Laws ch / Chuck Grassley / Ryan White / Kathleen Sebelius / Jim McDermott / David Vitter / /
Microsoft Word - FPC QHP Policy Guide Febdoc